Plain-English translation of NCT07046429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether melatonin, a natural hormone that helps regulate sleep, can improve both sleep quality and mental sharpness in people with cirrhosis (advanced liver disease). Cirrhosis often disrupts sleep and causes thinking problems that doctors currently struggle to treat well. The study will compare melatonin to thiamine (a B vitamin) to see which one works better for sleep and brain function.
People with cirrhosis frequently suffer from poor sleep and thinking difficulties, even when they're receiving standard treatments. Current medications used to treat these problems are expensive and hard to tolerate, so doctors need better, simpler options. This medication is being tested because it may help restore the body's natural sleep rhythms without the side effects of existing treatments.
You likely qualify if…
You likely don't qualify if…
You will take melatonin for one month, then stop for one week, then take thiamine for one month. Throughout the study, you'll wear a sleep-tracking device on your wrist (connected to an app on your phone) to monitor your sleep patterns continuously. Your thinking and sleep quality will be tested at the end of each month-long treatment period to see which medication helps you most.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States